These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2697759)

  • 1. The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues.
    Re RN
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():63-9. PubMed ID: 2697759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin and the regulation of cellular growth. Pathophysiologic implications for cardiovascular and noncardiovascular tissues.
    Re R
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):217S-219S. PubMed ID: 1710467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
    Paul M; Ganten D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S51-8. PubMed ID: 1381795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is angiotensin II a growth factor?].
    Clauser E; Bihoreau C; Monnot C; Teutsch B; Conchon S; Davies E; Corvol P
    Diabete Metab; 1992; 18(2 Pt 2):129-36. PubMed ID: 1639203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging issues in the cellular biology of the cardiovascular system.
    Re RN
    Am J Cardiol; 1988 Oct; 62(11):7G-12G. PubMed ID: 3051999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin and cell growth: a link to cardiovascular hypertrophy?
    Schelling P; Fischer H; Ganten D
    J Hypertens; 1991 Jan; 9(1):3-15. PubMed ID: 1848256
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
    Dzau VJ; Gibbons GH; Pratt RE
    Hypertension; 1991 Oct; 18(4 Suppl):II100-5. PubMed ID: 1916996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives.
    Antus B; Mucsi I; Rosivall L
    Acta Physiol Hung; 2000; 87(1):5-24. PubMed ID: 11032044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the study of the cellular biology of the cardiovascular system.
    Re R; Rovigatti U
    Circulation; 1988 Jun; 77(6 Pt 2):I14-7. PubMed ID: 3286042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.
    Tallant EA; Diz DI; Ferrario CM
    Hypertension; 1999 Oct; 34(4 Pt 2):950-7. PubMed ID: 10523390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
    Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
    J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial hypertrophy, angiotensin, and ACE inhibitors.
    Re RN
    Angiology; 1993 Nov; 44(11):875-81. PubMed ID: 8239059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular angiotensin pathways: a new therapeutic target.
    Dzau VJ
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S9-16. PubMed ID: 2485070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factors and cardiovascular structure. Implications for calcium antagonist therapy.
    Re RN; Chen L
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):460S-465S. PubMed ID: 1910639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular renin-angiotensin system and vascular protection.
    Dzau VJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S1-9. PubMed ID: 7508045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems?
    Fernández-Alfonso MS; González C
    J Hypertens; 1999 Oct; 17(10):1355-61. PubMed ID: 10526894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor modulation by Angiotensin II: a clue to a better understanding of the cardiovascular effects of renin-angiotensin system blockade?
    Celi A; Del Fiorentino A; Cianchetti S; Pedrinelli R
    Endocr Metab Immune Disord Drug Targets; 2008 Dec; 8(4):308-13. PubMed ID: 19075785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cell proliferation and growth by angiotensin II.
    Huckle WR; Earp HS
    Prog Growth Factor Res; 1994; 5(2):177-94. PubMed ID: 7919223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.